Allosteric inhibition abrogates dysregulated LFA-1 activation: Structural insight into mechanisms of diminished immunologic disease. - Maryam Abdullahi; Fisayo A. Olotu; Mahmoud E. S. Soliman (Comput. Biol. Chem., 2018)

Across the blood-brain barrier: Neurotherapeutic screening and characterization of naringenin as a novel CRMP-2 inhibitor in the treatment of Alzheimer's disease using bioinformatics and computational tools. - Maryam Lawal; Fisayo A. Olotu; Mahmoud E. S. Soliman (Comput. Biol. Medicine, 2018)

Drug promiscuity: Exploring the polypharmacology potential of 1, 3, 6-trisubstituted 1, 4-diazepane-7-ones as an inhibitor of the 'god father' of immune checkpoint. - Opeyemi S. Soremekun; Fisayo A. Olotu; Clement Agoni; Mahmoud E. S. Soliman (Comput. Biol. Chem., 2019)

Triple Mycobacterial ATP-synthase mutations impedes Bedaquiline binding: Atomistic and structural perspectives. - Elliasu Y. Salifu; Clement Agoni; Fisayo A. Olotu; Mahmoud E. S. Soliman (Comput. Biol. Chem., 2020)

Atomistic insights into the selective therapeutic activity of 6-(2, 4-difluorophenoxy)-5-((ethylmethyl)pyridine-3-yl)-8-methylpyrrolo[1, 2-a]pyrazin-1(2H)-one towards bromodomain-containing proteins. - Oluwole B. Akawa; Opeyemi S. Soremekun; Fisayo A. Olotu; Mahmoud E. S. Soliman (Comput. Biol. Chem., 2021)